Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析

◆英語タイトル:Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH139222FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) carries out the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw materials and preparations, bio-engineering drugs, and nutritious and health products. Its product portfolio includes suxiao jiuxin wan, ticlopidine hydrochloride tablets, cold soft capsules, verapamil hydrochloride tablets, anti-bone hyperplasia pill, pregnant women jinhua tablets, and diarrhea and sputum tablets, and others. TZPG also conducts research and development to develop new pharmaceutical products. The company’s products are used to treat cardiovascular disease, cold, vomit, diarrhea, dyspepsia, chemotherapy, diabetes, skin diseases, gastrointestinal and pneumonia. TZPG is headquartered in Tianjin, China.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Key Recent Developments

Apr 01,2021: Zhongxin Pharm won the award of “2019 Top 100 Chinese National Medicine Brand Enterprises”
Mar 28,2021: Announcement of Zhongxin Pharmaceutical on the tender offer of Jinhushen Biomedical Technology Co., Ltd. to acquire company shares

This comprehensive SWOT profile of Tianjin Zhongxin Pharmaceutical Group Corp Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tianjin Zhongxin Pharmaceutical Group Corp Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Information
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Overview
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Employees
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Employee Biographies
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Operational Heads
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Major Products and Services
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – History
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Company Statement
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Locations And Subsidiaries
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Business Description
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Corporate Strategy
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – SWOT Analysis
SWOT Analysis – Overview
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Strengths
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Weaknesses
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Opportunities
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Threats
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Information
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Ratios
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Share Data
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Major Products and Services
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, History
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Employees
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Employee Biographies
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Operational Heads
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Other Locations
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Subsidiaries
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Competitors
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, SWOT Analysis
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Ratios based on current share price
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Annual Ratios
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enea AB (ENEA):企業の財務・戦略的SWOT分析
    Summary Enea AB (Enea) is a technology company that provides software solutions. The company offers embedded technologies, testing and validation, certifications, software outsourcing, research and development centers, professional staffing and packaged services. It offers realtime operating system …
  • Bashas’ Inc.:企業の戦略・SWOT・財務情報
    Bashas' Inc. - Strategy, SWOT and Corporate Finance Report Summary Bashas' Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hindustan Oil Exploration Co Ltd (HINDOILEXP):企業の財務・戦略的SWOT分析
    Summary Hindustan Oil Exploration Co Ltd (HOEC) is an oil and gas exploration and development company. The company’s business activities include exploration and development of hydrocarbons crude oil and natural gas. It offers geological and geophysical services related to the exploration of oil and …
  • Software AG (SOW):企業の財務・戦略的SWOT分析
    Summary Software AG (SAG) is a technology company that provides software management solutions. The company offers digital business platform with integration, process management, adaptive application development, real-time analytics and enterprise architecture management. Its products include Adabas …
  • AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析
    AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Wegmans Food Markets, Inc.:企業の戦略・SWOT・財務分析
    Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • iBio Inc (IBIO):医療機器:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company that develops cell therapy products. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. The company’s lead product CLBS03 is …
  • Premier Foods plc (PFD):企業の財務・戦略的SWOT分析
    Premier Foods plc (PFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • MI Bioresearch Inc-医療機器分野:企業M&A・提携分析
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous m …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • Bravura Solutions Limited (BVA):企業の財務・戦略的SWOT分析
    Bravura Solutions Limited (BVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • MorphoSys AG (MOR):企業の財務・戦略的SWOT分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, and research applications. The company’s pipeline products include MOR208, MOR103, MOR202, MAA868, VAY736, MOR106, and MOR107. Its drugs are used for the treatment of various types of cancers, psoriasis, rheuma …
  • The Walsh Group:企業の戦略的SWOT分析
    The Walsh Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • All in West! Capital Corporation:企業の戦略・SWOT・財務情報
    All in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary All in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務情報
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sodexo SA:企業の戦略・SWOT・財務情報
    Sodexo SA - Strategy, SWOT and Corporate Finance Report Summary Sodexo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Children’s Medical Center:企業の戦略的SWOT分析
    Children's Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mizuho Financial Group Inc:企業の戦略・SWOT・財務情報
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆